reference/14826740

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14826740

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	53391
issn	1949-2553
issueIdentifier	33
pageRange	53377-53391
publicationName	Oncotarget
startingPage	53377
bibliographicCitation	Ghelli Luserna Di Rorà A, Iacobucci I, Imbrogno E, Papayannidis C, Derenzini E, Ferrari A, Guadagnuolo V, Robustelli V, Parisi S, Sartor C, Abbenante MC, Paolini S, Martinelli G. Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. Oncotarget. 2016 Aug 16;7(33):53377–91. PMID: 27438145; PMCID: PMC5288194.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f77c8ce1c9515ad1ecb50d2740be29e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5adc12a1f1de701d83e7da9229cb19cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3bf020da219679fab99e507306a5464 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8cdb97e62ae0f16995c6784026efd22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_024948067657a7dc862b447759cb559f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54bcb2d44d7c731d0586592cf1c13bd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83d2319e1798fcfbfc696bfeca64e141 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04cc12c2d2a08151e179ddcadbf39eee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b75c6ac01af104b58ada552e39a43c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e36b9f56987905e15a287dccc11297f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_023c78925bed7ddb2353ac2d28c3d1fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d3807fd8a2a87b5d38e4d87e061e7fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fd83e606bdc42fff1b3eee82f0a5362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6375-9343 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7022-9906
date	2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.18632/oncotarget.10535 https://pubmed.ncbi.nlm.nih.gov/PMC5288194 https://pubmed.ncbi.nlm.nih.gov/27438145
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803 https://portal.issn.org/resource/ISSN/1949-2553
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
discusses	http://id.nlm.nih.gov/mesh/M0217020 http://id.nlm.nih.gov/mesh/M0451044 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0186928 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0245645 http://id.nlm.nih.gov/mesh/M000618556 http://id.nlm.nih.gov/mesh/M0000352 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0217014 http://id.nlm.nih.gov/mesh/M0018225 http://id.nlm.nih.gov/mesh/M0001642 http://id.nlm.nih.gov/mesh/M0018226
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D011719Q000494 http://id.nlm.nih.gov/mesh/D000071877Q000037 http://id.nlm.nih.gov/mesh/D064447Q000037 http://id.nlm.nih.gov/mesh/D002453Q000187 http://id.nlm.nih.gov/mesh/D011720Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068877Q000494 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D000069439Q000494 http://id.nlm.nih.gov/mesh/D064447Q000378 http://id.nlm.nih.gov/mesh/D000071877Q000378 http://id.nlm.nih.gov/mesh/D000227Q000494 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D015452 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001087Q000494 http://id.nlm.nih.gov/mesh/D000077866 http://id.nlm.nih.gov/mesh/D054218
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46700756 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_744117db1e81ab1e4aebb6f186b13f7d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a423d85fa652b3ac7e8f59032ac788b2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_acc52e0f504ecc4eabefad797879545a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47e399ec321a86bc49eddbecff5cdd7b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c343e6a7c6ed1f53a79a52a5af338d66 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.22.56 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_848ea8bb1121ee393ad72ae0d412d8d2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11044 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4ea0ba22ce203dc7df620a257662b43e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46836099 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7b7931472271ea3bbbf8940c96433b42 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119182

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11200 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1111

Total number of triples: 89.